SEC Form D · Amendment · filed January 26, 2023
Sea Pharmaceuticals, LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Mark G. Currie · Cambridge, MADirectorWalter K. Brown · Cambridge, MADirectorMichael J. Higgins · Cambridge, MADirectorJames P. Pearson · Cambridge, MAExec · DirectorBenjamin J. Cravatt · Cambridge, MADirectorEric R. Olson · Cambridge, MADirectorNabil J. Elkouh · Cambridge, MADirectorShaker J. Sadasivam · Cambridge, MADirectorSam B. Crigman · CARPINTERIA, CAExec · DirectorCherry Chen · Dallas, TXDirectorCathy L. Berry · New York, NYDirectorKyle D. Miller · Dallas, TXDirectorJohn Todderud · Renton, WADirectorKathleen S. Marshall Lagambina · New York, NYDirectorBarbara S. Marshall · New York, NYDirectorMerrill Kaliser · Dallas, TXDirectorJames P. Mcconnell · SIMSBURY, CTExec · DirectorMohit Bhatnagar · Walnut, CADirectorEldon Klaassen · New York, NYDirectorPavel Khodorkovskiy · New York, NYDirectorThomas Blum · New York, NYDirectorBob Saris · Brooklyn, NYDirectorSean L. Sauler · New York, NYDirectorAdam L. Bensley · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗